Personalis Inc (PSNL)
5.635
+0.64
(+12.70%)
USD |
NASDAQ |
Nov 05, 16:00
5.60
-0.04
(-0.62%)
After-Hours: 18:53
Personalis Enterprise Value: 180.68M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 180.68M |
| November 01, 2024 | 185.46M |
| October 31, 2024 | 183.34M |
| October 30, 2024 | 190.77M |
| October 29, 2024 | 187.58M |
| October 28, 2024 | 189.71M |
| October 25, 2024 | 165.29M |
| October 24, 2024 | 164.76M |
| October 23, 2024 | 164.23M |
| October 22, 2024 | 164.76M |
| October 21, 2024 | 168.48M |
| October 18, 2024 | 173.78M |
| October 17, 2024 | 160.51M |
| October 16, 2024 | 169.01M |
| October 15, 2024 | 173.78M |
| October 14, 2024 | 157.86M |
| October 11, 2024 | 166.35M |
| October 10, 2024 | 177.50M |
| October 09, 2024 | 183.34M |
| October 08, 2024 | 191.83M |
| October 07, 2024 | 186.52M |
| October 04, 2024 | 190.77M |
| October 03, 2024 | 171.66M |
| October 02, 2024 | 171.13M |
| October 01, 2024 | 176.97M |
| Date | Value |
|---|---|
| September 30, 2024 | 200.85M |
| September 27, 2024 | 192.36M |
| September 26, 2024 | 189.17M |
| September 25, 2024 | 162.64M |
| September 24, 2024 | 172.19M |
| September 23, 2024 | 184.13M |
| September 20, 2024 | 219.96M |
| September 19, 2024 | 230.04M |
| September 18, 2024 | 208.28M |
| September 17, 2024 | 216.24M |
| September 16, 2024 | 208.28M |
| September 13, 2024 | 217.30M |
| September 12, 2024 | 219.43M |
| September 11, 2024 | 231.10M |
| September 10, 2024 | 221.55M |
| September 09, 2024 | 197.67M |
| September 06, 2024 | 200.32M |
| September 05, 2024 | 189.17M |
| September 04, 2024 | 201.38M |
| September 03, 2024 | 192.36M |
| August 30, 2024 | 204.04M |
| August 29, 2024 | 223.14M |
| August 28, 2024 | 208.81M |
| August 27, 2024 | 221.02M |
| August 26, 2024 | 223.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-114.38M
Minimum
Jun 17 2022
1.792B
Maximum
Jan 20 2021
248.94M
Average
129.37M
Median
Apr 08 2020
Enterprise Value Benchmarks
| Repligen Corp | 7.600B |
| Myriad Genetics Inc | 1.561B |
| Axogen Inc | 648.30M |
| CareDx Inc | 983.09M |
| Perspective Therapeutics Inc | 530.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.80M |
| Revenue (Quarterly) | 22.58M |
| Total Expenses (Quarterly) | 39.47M |
| EPS Diluted (Quarterly) | -0.24 |
| Gross Profit Margin (Quarterly) | 35.59% |
| Profit Margin (Quarterly) | -56.70% |
| Earnings Yield | -29.10% |
| Normalized Earnings Yield | -26.36 |